Abstract
Ischemia-reperfusion (IR) is a complication that can raise the risk of death after lung transplantation, by activating the innate immune system to induce inflammation. This occurs when the supplemental oxygen in the lungs is stopped (ischemia) followed by reperfusion period. During ischemia, oxygen supply is below metabolic needs, resulting in depletion of cellular reserves of ATP and inc…